Acknowledgements This work was partially funded by the Italian Ministry of Education (MIUR, Grant to GS) and by Sigma Tau Industrie Farmaceutiche Riunite (Grant to GR)
Cardiovascular Diabetology
Under the brand name Victoza, it's approved to treat type 2 diabetes, while under the brand name Saxenda, it's approved for weight loss
M., Deussen, A
Motus (oral) reported notable human clinical trial results for an oral supplement, and that difference - oral versus injectable - matters for many peoples preferences and lifestyles
Massimiliano Casu, Nicola Butler, Dr Carlo Breda, Dr Susanna Campesan, Dr Jannine Clapp, Dr Edward Green and Devyani Dhulkhed also contributed to the research study